Wave Life Sciences (WVE) Equity Average (2016 - 2025)
Historic Equity Average for Wave Life Sciences (WVE) over the last 11 years, with Q3 2025 value amounting to $131.9 million.
- Wave Life Sciences' Equity Average rose 9094.48% to $131.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $131.9 million, marking a year-over-year increase of 9094.48%. This contributed to the annual value of $124.6 million for FY2024, which is 466225.97% up from last year.
- According to the latest figures from Q3 2025, Wave Life Sciences' Equity Average is $131.9 million, which was up 9094.48% from $155.5 million recorded in Q2 2025.
- Wave Life Sciences' Equity Average's 5-year high stood at $190.7 million during Q1 2025, with a 5-year trough of -$46.1 million in Q3 2023.
- For the 5-year period, Wave Life Sciences' Equity Average averaged around $43.1 million, with its median value being $25.9 million (2021).
- Its Equity Average has fluctuated over the past 5 years, first tumbled by 44889.51% in 2023, then soared by 4112278.04% in 2024.
- Over the past 5 years, Wave Life Sciences' Equity Average (Quarter) stood at $31.2 million in 2021, then tumbled by 179.5% to -$24.8 million in 2022, then surged by 98.27% to -$428000.0 in 2023, then surged by 41122.78% to $175.6 million in 2024, then fell by 24.87% to $131.9 million in 2025.
- Its last three reported values are $131.9 million in Q3 2025, $155.5 million for Q2 2025, and $190.7 million during Q1 2025.